SB 1054 Pennsylvania Senate · 2017-2018 Regular Session

An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.

Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2018
Committee Review
Floor Vote
Governor
Introduced Feb 16, 2018 Last action May 23, 2018
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
3
May 23, 2018
Committee
Re-referred to APPROPRIATIONS
upper
May 22, 2018
Upper · Passed
PN 1773 Reported as amended
upper
Feb 16, 2018
Committee
PN 1489 Referred to HEALTH AND HUMAN SERVICES
upper
1 primary · 4 co-sponsors

Sponsors